Reported Gastrointestinal Side Effects in Clinical Trials Phase 2 trial data show nausea, vomiting, diarrhoea, constipation, and upper abdominal pain are the most frequently reported gastrointestinal side effects, with incidence increasing at higher doses and most events being mild to moderate
Implemented dietary supplementation with microbe-derived antioxidants induced beneficial biochemical changes in plasma parameters [83] without any negative clinical effects in healthy Beagle dogs
Journal of the Academy of Nutrition and Dietetics, 118(10), 18321843
In SURMOUNT-2, participants were randomized 1:1:1 to once-weekly, subcutaneous tirzepatide (10 or 15 mg) or placebo for 72 weeks, followed by a 4-week safety follow-up period without treatment
Pull at the capsule ends with the tips of your fingers